These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35848898)

  • 21. Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma.
    Zeng Y; Zeng Y; Yin H; Chen F; Wang Q; Yu X; Zhou Y
    Aging (Albany NY); 2021 Jan; 13(3):3459-3482. PubMed ID: 33428606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNFR-associated factor 6 and TGF-β-activated kinase 1 control signals for a senescence response by an endosomal NK cell receptor.
    Rajagopalan S; Lee EC; DuPrie ML; Long EO
    J Immunol; 2014 Jan; 192(2):714-21. PubMed ID: 24337384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma.
    Lu C; Wang Y; Nie L; Chen L; Li M; Qing H; Li S; Wu S; Wang Z
    Front Immunol; 2022; 13():934243. PubMed ID: 36189255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
    Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
    Front Immunol; 2022; 13():997765. PubMed ID: 36275664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KIR2DL4 promotes the proliferation of RCC cell associated with PI3K/Akt signaling activation.
    Ding XF; Chen J; Ma HL; Liang Y; Wang YF; Zhang HT; Li X; Chen G
    Life Sci; 2022 Mar; 293():120320. PubMed ID: 35063466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
    Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
    Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
    Song J; Yang R; Wei R; Du Y; He P; Liu X
    Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma.
    Shou Y; Yang L; Yang Y; Zhu X; Li F; Xu J
    Mol Omics; 2021 Apr; 17(2):307-316. PubMed ID: 33624645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis.
    Frazao A; Rethacker L; Jeudy G; Colombo M; Pasmant E; Avril MF; Toubert A; Moins-Teisserenc H; Roelens M; Dalac S; Maubec E; Caignard A
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32912923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies.
    Xu Y; Chen Y; Niu Z; Xing J; Yang Z; Yin X; Guo L; Zhang Q; Qiu H; Han Y
    Front Med (Lausanne); 2022; 9():841568. PubMed ID: 35492358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic mechanisms of age-dependent KIR2DL4 expression in T cells.
    Li G; Weyand CM; Goronzy JJ
    J Leukoc Biol; 2008 Sep; 84(3):824-34. PubMed ID: 18586981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for balancing selection acting on KIR2DL4 genotypes in rhesus macaques of Indian origin.
    Blokhuis JH; van der Wiel MK; Doxiadis GG; Bontrop RE
    Immunogenetics; 2009 Jul; 61(7):503-12. PubMed ID: 19506858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel cellular senescence-related signature for the prediction of prognosis and immunotherapy response in colon cancer.
    Dai L; Wang X; Bai T; Liu J; Chen B; Li T; Yang W
    Front Genet; 2022; 13():961554. PubMed ID: 35991564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma.
    Yu X; Chen P; Yi W; Ruan W; Xiong X
    Front Immunol; 2022; 13():1029872. PubMed ID: 36275676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyroptosis-related gene mediated modification patterns and immune cell infiltration landscapes in cutaneous melanoma to aid immunotherapy.
    Meng J; Huang X; Qiu Y; Zheng X; Huang J; Wen Z; Yao J
    Aging (Albany NY); 2021 Nov; 13(21):24379-24401. PubMed ID: 34753832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma.
    Guo S; Chen J; Yi X; Lu Z; Guo W
    Front Immunol; 2022; 13():985051. PubMed ID: 36248853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.